Thermal ablation and cryotherapy for cervical precancer
Destroying precancerous cervical cells with a heated or frozen probe in under a minute, the tool that makes screen-and-treat possible where there are no surgeons.
WHO (2019) recommends thermal ablation (100°C probe, 20-40 seconds) or cryotherapy for eligible CIN2+ lesions in screen-and-treat programmes, often after visual inspection with acetic acid (VIA) or HPV testing. Portable battery-powered devices cost a few hundred dollars; cure rates ~85-95% for eligible lesions. Central to the WHO cervical cancer elimination strategy's 90% treatment target.
How it works
Coagulative necrosis (thermal) or freeze-thaw injury (cryo) of the cervical transformation zone.
- Cheap, fast, no anaesthesia or electricity mains
- Enables single-visit screen-and-treat
- No histology
- Not suitable for large or endocervical lesions
Latest papers
topQuery for this technology: (TITLE:"Thermal ablation and cryotherapy for cervical precancer" OR ABSTRACT:"Thermal ablation and cryotherapy for cervical precancer") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Thermal ablation and cryotherapy for cervical precancer, not a curated reading list.
Pages like this
not linked directly; found by shared links- TechnologyColposcopy and excisional treatment (LEEP/LLETZ, cone)
Shares Cervical precancer (CIN, HSIL/LSIL), Basement membrane & tissue barriers, HPV DNA testing and self-sampling, Cervical cancer.
- PersonJade Goody
Shares Cervical precancer (CIN, HSIL/LSIL), HPV DNA testing and self-sampling, Prevention we already have is not deployed, Cervical cancer.
- Key paperSwedish registry study: HPV vaccination almost eliminates cervical cancer when given before 17
Shares Single-dose HPV vaccination plus HPV self-sampling to reach WHO elimination in low-income countries, HPV DNA testing and self-sampling, Prevention we already have is not deployed, Most of the world has almost no cancer care.
- PersonHarald zur Hausen
Shares Cervical precancer (CIN, HSIL/LSIL), HPV DNA testing and self-sampling, Anal cancer (squamous cell carcinoma), Prevention we already have is not deployed.
- ProductNonavalent HPV vaccine
Shares Single-dose HPV vaccination plus HPV self-sampling to reach WHO elimination in low-income countries, Anal cancer (squamous cell carcinoma), Prevention we already have is not deployed, Most of the world has almost no cancer care.
- TermBarrett's oesophagus
Shares Intercept cancer at the field stage, Basement membrane & tissue barriers, Field cancerisation.
- TrialKEN SHE (single-dose HPV vaccine)
Shares Single-dose HPV vaccination plus HPV self-sampling to reach WHO elimination in low-income countries, Prevention we already have is not deployed, Cervical cancer.
- Key paperEngland's HPV programme: cervical cancer down 87% in the first cohort vaccinated at 12-13
Shares HPV DNA testing and self-sampling, Prevention we already have is not deployed, Most of the world has almost no cancer care, Cervical cancer.